Lilian Amrein
Lilian Amrein is an expert in Pharmacy at Unicancer (France). Lilian Amrein has authored 26 publications, the most recent in 2020. SLR score: 72 (community average: 125). How the SLR is computed.
LeadR Profile
Pharmacy
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2007 - 2026
Number : 26
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia. PMID 32154751 — lymphoma, hypertension, biomarkers, fatigue, hyperglycemia, neoplasms, phosphatidylinositol 3-kinases, leukemia, lymphocytic, chronic, b-cell, leukemia, lymphoid, ribosomal protein s6 kinases, 70-kda, phosphatidylinositols, phosphatidylinositol 3-kinase | Leuk Lymphoma | 2020 | 7 |
| PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines. PMID 30039287 — cell cycle, apoptosis, neoplasm metastasis, cells, breast neoplasms, cell line, poly adenosine diphosphate ribose, tubulin, vinorelbine | Breast Cancer Res Treat | 2018 | 27 |
| Precision spherical nucleic acids for delivery of anticancer drugs. PMID 28989655 — blood-brain barrier, blood, nanoparticles, pharmaceutical preparations, brain, neoplasms, nucleic acids, therapeutics | Chem Sci | 2017 | 104 |
| Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan. PMID 26257651 — cells, poly(adp-ribose) polymerases, inhibitory concentration 50, pharmaceutical preparations, neoplasms, colon, poly adenosine diphosphate ribose, drug therapy, cell line, ataxia telangiectasia, protein serine-threonine kinases, irinotecan, adenosine diphosphate ribose, hct116 cells, colonic neoplasms, chemotherapy | Front Pharmacol | 2015 | 20 |
| Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell lines. PMID 23341105 — chromosome aberrations, cell transformation, neoplastic, cells, breast neoplasms, genes, brca1, genes, brca2, mutation, mitomycin, maintenance, cell line, centromere, telomere | Genes Chromosomes Cancer | 2013 | 8 |
LeadR Networks
Main global connection map